AI Is Reinventing the Way We Invent

February 18, 2019

(MIT Technology Review) – The problem is that human researchers can explore only a tiny slice of what is possible. It’s estimated that there are as many as 1060 potentially drug-like molecules—more than the number of atoms in the solar system. But traversing seemingly unlimited possibilities is what machine learning is good at. Trained on large databases of existing molecules and their properties, the programs can explore all possible related molecules.

Posted by

Posted in Biotech, News, Pharma

Recommended Reading